This activity is part of an ongoing CME/CE initiative to provide information on labeling changes reported by the FDA. Activities of this nature will be posted on Medscape on a weekly basis. July 29, ...
Add Yahoo as a preferred source to see more of our stories on Google. (WHNT) — The Alabama Department of Public Health issued a statement Wednesday about its current investigation into certain ...
July 6, 2007 (updated September 11, 2007) — The safety labeling for ceftriaxone sodium injection ( Rocephin; Roche Pharmaceuticals, Inc) has been updated to describe the potential risks associated ...
Add Yahoo as a preferred source to see more of our stories on Google. Jan. 24—The Alabama Department of Public Health is investigating some reports of adverse reactions to injections of the antibiotic ...
The FDA has notified healthcare professionals of an update to a previous alert from September 2007 addressing the interaction of ceftriaxone with calcium-containing products. At the FDA’s request, ...
FLORENCE — Several health care providers in the Shoals continue to press pause on giving the antibiotic injection ceftriaxone, which is commonly known as Rocephin, after reports of “adverse effects” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results